Literature DB >> 28322459

Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway.

Ge-Liang Liu1, Han-Jie Yang1, Bo Liu2, Tian Liu2.   

Abstract

Wilms' tumor (WT) is a most common renal cancer that occurs among children, and microRNA-19b (miR-19b) usually participates in various human cancers. Importantly, the PTEN/PI3K/Akt signaling pathway plays a key role in cell apoptosis, growth and proliferation. Thus, our present study aims to investigate the effect of miR-19b on the PTEN/PI3K/Akt signaling pathway during WT cell proliferation, migration, and apoptosis. WT tissues and adjacent normal tissues from WT patients were collected. qRT-PCR was applied to detect miR-19b expression in both the WT tissues and the adjacent normal tissues, immunohistochemistry was applied to detect the protein expressions of PTEN, P13K, and p-Akt, SK-NEP-1 cells were divided into the blank, negative control (NC), miR-19b mimics and miR-19b inhibitors groups. MTT assay, propidium iodide (PI) staining, Annexin-V/PI double-staining, Transwell assay and Western blotting were performed to examine cell proliferation, cycle, apoptosis, migration, and invasion, and the protein expressions of PTEN, P13K, Akt, and p-Akt. Increased miR-19b expression, positive expression rates of P13K and Akt, decreased PTEN expression rate, a negative correlation between PTEN expression and tumor lymph node metastasis, and a positive correlation between the expression of P13K and Akt and the clinical stages were observed in the WT tissues. The miR-19b inhibitors group exhibited decreased cell proliferation, cell cycle progression, migration and invasion, and protein expressions of PI3K and p-Akt but increased PTEN protein expression compared with the blank and NC groups. Thus, inhibition of miR-19b suppresses the progression of WT by modulating the PTEN/PI3K/AKT signaling pathway. J. Cell. Biochem. 118: 3424-3434, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CELL APOPTOSIS; CELL MIGRATION; CELL PROLIFERATION; MICRORNA-19B; PTEN/P13K/AKT SIGNALING PATHWAY; WILMS’ TUMOR

Mesh:

Substances:

Year:  2017        PMID: 28322459     DOI: 10.1002/jcb.25999

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  22 in total

1.  MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.

Authors:  Chang Chai; Lai-Jun Song; Shuang-Yin Han; Xi-Qing Li; Ming Li
Journal:  CNS Neurosci Ther       Date:  2018-01-05       Impact factor: 5.243

2.  Investigating the dysfunctional pathogenesis of Wilms' tumor through a multidimensional integration strategy.

Authors:  Wenbiao Chen; Jia Zhuang; Lan Gong; Yong Dai; Hongyan Diao
Journal:  Ann Transl Med       Date:  2019-04

3.  Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.

Authors:  Yunfeng Ding; Wanbo Wu; Zhihong Ma; Xia Shao; Ming Zhang; Zhanwei Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

4.  MicroRNA-498 inhibits the proliferation, migration and invasion of gastric cancer through targeting BMI-1 and suppressing AKT pathway.

Authors:  Dong You; Dawei Wang; Peiji Liu; Yuning Chu; Xueying Zhang; Xueli Ding; Xiaoyu Li; Tao Mao; Xue Jing; Zibin Tian; Yinghua Pan
Journal:  Hum Cell       Date:  2020-02-13       Impact factor: 4.374

5.  Long non-coding RNA phosphatase and tensin homolog pseudogene 1 suppresses osteosarcoma cell growth via the phosphoinositide 3-kinase/protein kinase B signaling pathway.

Authors:  Bin Yan; Aikepaer Wubuli; Yidong Liu; Xin Wang
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

6.  Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.

Authors:  Zifeng Liu; Wenbo Zhao; Yuqing Ren; Chang Liu; Xun Liu; Jian Xiao
Journal:  Oncol Lett       Date:  2020-03-31       Impact factor: 2.967

7.  MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells.

Authors:  Taicheng Zhou; Lili Wu; Qirui Wang; Zhipeng Jiang; Yingru Li; Ning Ma; Wenhao Chen; Zehui Hou; Wenchang Gan; Shuang Chen
Journal:  Oncol Lett       Date:  2018-09-26       Impact factor: 2.967

8.  miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.

Authors:  Ulrich Baumgartner; Fabienne Berger; Ali Hashemi Gheinani; Sabrina Sofia Burgener; Katia Monastyrskaya; Erik Vassella
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

9.  MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway.

Authors:  Zi-Wen Long; Jiang-Hong Wu; Ya-Nong Wang; Ye Zhou
Journal:  Mol Cells       Date:  2018-06-14       Impact factor: 5.034

Review 10.  Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.

Authors:  Ningni Jiang; Qijie Dai; Xiaorui Su; Jianjiang Fu; Xuancheng Feng; Juan Peng
Journal:  Mol Biol Rep       Date:  2020-04-24       Impact factor: 2.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.